Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
De Gruyter ; 2020 |
Reproduktion: |
Walter de Gruyter Online Zeitschriften |
---|---|
Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
Enthalten in: |
Clinical chemistry and laboratory medicine - 58(2020), 12 vom: 27. Aug., Seite 2121-2130 |
Beteiligte Personen: |
Haselmann, Verena [Sonstige Person] |
---|
Links: |
doi.org [Deutschlandweit zugänglich] |
---|
Themen: |
COVID-19 |
---|
Umfang: |
10 |
---|
doi: |
10.1515/cclm-2020-1183 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLEJ24795666X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLEJ24795666X | ||
003 | DE-627 | ||
005 | 20230506090300.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220814s2020 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1515/cclm-2020-1183 |2 doi | |
028 | 5 | 2 | |a articles2015-2020.pp |
035 | |a (DE-627)NLEJ24795666X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
245 | 1 | 0 | |a Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing |
264 | 1 | |b De Gruyter |c 2020 | |
300 | |a 10 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
533 | |f Walter de Gruyter Online Zeitschriften | ||
650 | 4 | |a COVID-19 | |
650 | 4 | |a external quality assessment scheme | |
650 | 4 | |a proficiency testing | |
650 | 4 | |a ring trial | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Haselmann, Verena |4 oth | |
700 | 1 | |a Özçürümez, Mustafa K. |4 oth | |
700 | 1 | |a Klawonn, Frank |4 oth | |
700 | 1 | |a Ast, Volker |4 oth | |
700 | 1 | |a Gerhards, Catharina |4 oth | |
700 | 1 | |a Eichner, Romy |4 oth | |
700 | 1 | |a Costina, Victor |4 oth | |
700 | 1 | |a Dobler, Gerhard |4 oth | |
700 | 1 | |a Geilenkeuser, Wolf-Jochen |4 oth | |
700 | 1 | |a Wölfel, Roman |4 oth | |
700 | 1 | |a Neumaier, Michael |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d Berlin [u.a.] : De Gruyter, 1998 |g 58(2020), 12 vom: 27. Aug., Seite 2121-2130 |w (DE-627)NLEJ248235222 |w (DE-600)1492732-9 |x 1437-4331 |7 nnns |
773 | 1 | 8 | |g volume:58 |g year:2020 |g number:12 |g day:27 |g month:08 |g pages:2121-2130 |g extent:10 |
856 | 4 | 0 | |u https://doi.org/10.1515/cclm-2020-1183 |z Deutschlandweit zugänglich |
912 | |a GBV_USEFLAG_U | ||
912 | |a ZDB-1-DGR | ||
912 | |a GBV_NL_ARTICLE | ||
951 | |a AR | ||
952 | |d 58 |j 2020 |e 12 |b 27 |c 08 |h 2121-2130 |g 10 |